Clinical Trials
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual agonist in obesity/diabetes
Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical trial of the long-acting GLP-1/glucagon dual agonist BI 456906, which Zealand has licensed to Boehringer Ingelheim. As part of the license agreement, Zealand will...
News
EPG Health launches Medthority, a medical website personalised for doctors and tailored for pharma
When providing medical information online, enhanced user experience (UX) is the key to delivering real according to digital medical publisher EPG Health. Such is their reason for launching Medthority (www.medthority.com), to replace the companyโs previous website for healthcare professionals...
Drug Research
Piramal Pharma Announces Acquisition of Solid Oral Dosage Drug Product Facility in Pennsylvania from G&W Laboratories
Piramal Enterprises Limitedโs (PEL) Pharma Solutions business, a contract development and manufacturing organization, has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, PA. According to the...
News
Gemini Bio opens new manufacturing facility in West Sacramento, California
Gemini Bioproducts, LLC, a leading supplier of cell culture reagents and a portfolio company of BelHealth Investment Partners, LLC, a New York-based healthcare private equity firm,ย announced the opening of a new, state-of-the-art manufacturing facility in West Sacramento, California.
Gemini...
News
WuXi NextCODE Restructures and Becomes Genuity Science
WuXi NextCODE announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for customers, and new collaborations with industry partners. As part of these efforts, effective June 23, 2020,...
News
Uniphar and Inther Group join forces
Uniphar, a supplier of medical supplies and a global partner of pharmaceutical and medtech manufacturers, has engaged system integrator Inther Group to realize a large automation project at their DC in Ireland. It will be a completely new system...
News
OpenCell Technologies Appoints CEO
OpenCell Technologies, an R&D-stage biomedical venture, has appointed Kevin Gutshall as chief executive officer to lead efforts to translate and commercialize its core technology platform, POROS. Kevin joins the company from MilliporeSigma where he served as director of life...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















